Prime Medicine
Meredith Goldwasser joined Prime Medicine in September 2020 as Head of Strategy and Corporate Operations.
Dr. Goldwasser has spent the last 19 years developing new drugs in the biopharmaceutical industry working across all phases of clinical development, and in various roles in project leadership, business development and company building. She is a demonstrated strategic leader with broad experience in oncology, rare genetic diseases and data sciences. Most recently she was the development leader for the IDH Hematology program and oncology business development lead at Agios, where she also helped to build the clinical development and data sciences group. Prior to Agios, she held roles of increasing responsibility at Novartis and Genentech which contributed to the development and approval of multiple oncology products. Meredith holds a ScD in biostatistics from Harvard University, after which she worked as a research scientist at the Dana Farber Cancer Institute. She holds a BA from the University of Pennsylvania.
This person is not in any offices
Prime Medicine
4 followers
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.